Approximately 2-8% of kidney cancer is associated with a strong hereditary cancer predisposition. There are now over a dozen recognized genes associated with a hereditary kidney cancer syndromes. While other cancer fields have clear guidelines on germline assessment, kidney cancer lacks clear consensus leading to variation on referral patterns and barriers to insurance coverage. The objective of this conference is to convene an expert panel to initiate and publish guidelines for counseling and testing.
Who: Any kidney cancer/genetics provider or researcher with strong
interest in hereditary cancer syndromes are welcome to participate
What: A panel of experts will discuss the current state of hereditary risk
assessment for kidney cancer.
Where: Westin Hotel, Whitman Meeting Room, 99 South 17th Street, Philadelphia, PA 19103
When: September 12th, 2019, 8:00 -11:00 AM
This Meeting Precedes the Kidney Cancer Research Summit located adjacent to the Convene CityView Conference Center.
RSVP: email@example.com or firstname.lastname@example.org
Brian Shuch, MD: David Geffen School of Medicine at UCLA
Gennady Bratslavsky, MD: SUNY Upstate Medical University
Eric Jonash, MD: MD Anderson Cancer Center
Ramaprasad Srinivasan, MD, PhD: National Cancer Institute
Othon Iliopoulos, MD: Mass General Hospital
Keynote Address: Marston Linehan, MD: National Cancer Institute
Sponsor: The Department of Urology at Upstate Medical University